![](/img/cover-not-exists.png)
Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
Sageshima, Junichiro, Burke, George, Ciancio,, Chen,Journal:
Biologics: Targets & Therapy
DOI:
10.2147/BTT.S3258
Date:
June, 2009
File:
PDF, 269 KB
2009